REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, today announced the appointment of David L. Szekeres as Senior Vice President of Business Development, General Counsel and Corporate Secretary. Mr. Szekeres joins the Company today and will report to Barry D. Quart, Pharm.D., Chief Executive Officer of Heron.
